Cambridge, MA, United States of America

Justin W Jackson

This inventor holds 12 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Scholar Rock, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin W Jackson. Retrieved from https://idiyas.com/inventor/justin-w-jackson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 9.1

ph-index = 2

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations by Inventor Justin W. Jackson in Cambridge, MA

Introduction

Justin W. Jackson, a notable inventor based in Cambridge, Massachusetts, has made significant contributions to the field of biotechnology. With a total of eight patents to his name, he focuses primarily on innovative therapeutic methods and inhibitors that target the TGFβ signaling pathway, which is crucial in various fibrotic disorders.

Latest Patents

Among his latest patents, Jackson has developed 'LTBP complex-specific inhibitors of TGFβ and uses thereof'. This patent discloses inhibitors, such as antibodies and antigen-binding fragments that selectively bind to LTBP1-TGFβ and/or LTBP3-TGFβ complexes. The application emphasizes the potential therapeutic methods for inhibiting TGFβ activation and treating subjects affected by TGFβ-related ailments, like fibrotic conditions. Additionally, he has patented 'Isoform-selective TGFB1 inhibitors and use thereof', which details monoclonal antibodies designed to selectively inhibit TGFβ1 with high potency, outlining related compositions and therapeutic applications.

Career Highlights

Justin W. Jackson serves as an integral member of Scholar Rock, Inc., where his expertise in molecular biology and pharmacology is put to use in developing groundbreaking therapies. His contributions have strengthened the company's reputation in the biotech industry, particularly in the context of diseases linked to TGFβ signaling.

Collaborations

Throughout his career, Jackson has collaborated with talented colleagues like Thomas Schurpf and Abhishek Datta, combining their expertise to advance the understanding and treatment of fibrotic conditions. Their collaborative efforts emphasize the importance of teamwork in the innovation process, leading to the successful development of multiple patents.

Conclusion

In conclusion, Justin W. Jackson's innovative work at Scholar Rock, Inc. underscores his significant role as an inventor dedicated to addressing complex health challenges through targeted therapies. His remarkable contributions to the field have not only propelled advancements in medical science but also inspired future research in related areas.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…